Arcutis Biotherapeutics Inc (ARQT)
9.08
-0.84
(-8.47%)
USD |
NASDAQ |
May 23, 16:00
9.45
+0.37
(+4.07%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash and Short Term Investments (Quarterly): 403.87M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 403.87M |
December 31, 2023 | 271.86M |
September 30, 2023 | 227.11M |
June 30, 2023 | 268.67M |
March 31, 2023 | 332.40M |
December 31, 2022 | 409.59M |
September 30, 2022 | 476.96M |
June 30, 2022 | 282.17M |
March 31, 2022 | 343.60M |
December 31, 2021 | 387.06M |
Date | Value |
---|---|
September 30, 2021 | 367.27M |
June 30, 2021 | 409.36M |
March 31, 2021 | 444.93M |
December 31, 2020 | 284.44M |
September 30, 2020 | 189.71M |
June 30, 2020 | 223.98M |
March 31, 2020 | 249.32M |
December 31, 2019 | 101.26M |
September 30, 2019 | 25.18M |
December 31, 2018 | 50.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
25.18M
Minimum
Sep 2019
476.96M
Maximum
Sep 2022
299.93M
Average
284.44M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
AdaptHealth Corp | 79.57M |
Prestige Consumer Healthcare Inc | 46.47M |
Pfizer Inc | 11.93B |
Adverum Biotechnologies Inc | 193.33M |
Karuna Therapeutics Inc (DELISTED) | 1.263B |